• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


79.500 EUR 1.940 2.38%

As of 12:28:05 ET on 07/31/2014.

Snapshot for Biotest AG (BIO3)

Open: 81.230 Day's Range: 78.590 - 82.160 Volume: 60,274
Previous Close: 81.440 52wk Range: 52.381 - 100.000 1-Yr Rtn: +46.50%

Stock Chart for BIO3

No chart data available.
  • BIO3:GR 79.500
  • 1D
  • 1M
  • 1Y
Interactive BIO3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIO3

Current P/E Ratio (ttm) 33.0669
Estimated P/E(12/2014) 28.0746
Relative P/E vs. DAX 1.8402
Earnings Per Share (EUR) (ttm) 2.3900
Est. EPS (EUR) (12/2014) 2.8150
Est. PEG Ratio -
Market Cap (M EUR) 1,036.38
Shares Outstanding (M) 6.60
30 Day Average Volume 11,316
Price/Book (mrq) 2.2539
Price/Sale (ttm) 1.9880
Dividend Indicated Gross Yield 0.80%
Cash Dividend (EUR) 0.6300
Dividend Ex-Date 05/08/2014
5 Year Dividend Growth 11.89%
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIO3

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BIO3

Biotest AG develops, produces and markets pharmaceuticals, as well as diagnostic and testing products and equipment for human and veterinarian applications. The Company provides a wide range of immune, molecular-biological and antibody test systems, as well as medical test devices. Biotest manages research and production operations mainly in Europe and sells its products worldwide.

Gregor SchulzChairman-Mgmt BoardMichael RamrothCFO/Member-Mgmt Board
Georg FlossMember-Mgmt Board
More Company Profile & Key Executives for BIO3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil